Arthur M Krieg - Net Worth and Insider Trading
Arthur M Krieg Net Worth
The estimated net worth of Arthur M Krieg is at least $8 Million dollars as of 2024-12-27. Arthur M Krieg is the Chief Scientific Officer of Checkmate Pharmaceuticals Inc and owns about 808,510 shares of Checkmate Pharmaceuticals Inc (CMPI) stock worth over $8 Million. Details can be seen in Arthur M Krieg's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Arthur M Krieg has not made any transactions after 2021-06-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Arthur M Krieg
Arthur M Krieg Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Arthur M Krieg owns 2 companies in total, including Checkmate Pharmaceuticals Inc (CMPI) , and Sarepta Therapeutics Inc (SRPT) .
Click here to see the complete history of Arthur M Krieg’s form 4 insider trades.
Insider Ownership Summary of Arthur M Krieg
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CMPI | Checkmate Pharmaceuticals Inc | 2021-06-16 | director & Chief Scientific Officer |
| SRPT | Sarepta Therapeutics Inc | 2014-01-13 | SVP & Chief Scientific Officer |
Arthur M Krieg Latest Holdings Summary
Arthur M Krieg currently owns a total of 1 stock. Arthur M Krieg owns 808,510 shares of Checkmate Pharmaceuticals Inc (CMPI) as of June 16, 2021, with a value of $8 Million.
Latest Holdings of Arthur M Krieg
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CMPI | Checkmate Pharmaceuticals Inc | 2021-06-16 | 808,510 | 10.50 | 8,489,355 |
Holding Weightings of Arthur M Krieg
Arthur M Krieg Form 4 Trading Tracker
According to the SEC Form 4 filings, Arthur M Krieg has made a total of 9 transactions in Checkmate Pharmaceuticals Inc (CMPI) over the past 5 years, including 9 buys and 0 sells. The most-recent trade in Checkmate Pharmaceuticals Inc is the acquisition of 3,578 shares on June 16, 2021, which cost Arthur M Krieg around $22,112.
Insider Trading History of Arthur M Krieg
- 1
Arthur M Krieg Trading Performance
GuruFocus tracks the stock performance after each of Arthur M Krieg's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Arthur M Krieg is -31.53%. GuruFocus also compares Arthur M Krieg's trading performance to market benchmark return within the same time period. The performance of stocks bought by Arthur M Krieg within 3 months outperforms 0 times out of 9 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Arthur M Krieg's insider trading performs compared to the benchmark.
Performance of Arthur M Krieg
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -13.25 | | | | | |
| Relative Return to S&P 500(%) | -16.02 | | | | | |
Arthur M Krieg Ownership Network
Arthur M Krieg Owned Company Details
What does Checkmate Pharmaceuticals Inc do?
Who are the key executives at Checkmate Pharmaceuticals Inc?
Arthur M Krieg is the director & Chief Scientific Officer of Checkmate Pharmaceuticals Inc. Other key executives at Checkmate Pharmaceuticals Inc include 10 percent owner Venbio Global Strategic Fund Ii L.p. , director & Chief Executive Officer Alan Bash , and 10 percent owner Novo Holdings A/s .
Checkmate Pharmaceuticals Inc (CMPI) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Checkmate Pharmaceuticals Inc (CMPI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Checkmate Pharmaceuticals Inc (CMPI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Checkmate Pharmaceuticals Inc (CMPI)'s detailed insider trading history can be found in Insider Trading Tracker table.
Checkmate Pharmaceuticals Inc Insider Transactions
Arthur M Krieg Mailing Address
Above is the net worth, insider trading, and ownership report for Arthur M Krieg. You might contact Arthur M Krieg via mailing address: C/o Checkmate Pharmaceuticals, Inc., 245 Main Street, 2nd Floor, Cambridge Ma 02142.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
